BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harrell CR, Volarevic A, Djonov VG, Jovicic N, Volarevic V. Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity. Int J Mol Sci 2021;22:12429. [PMID: 34830312 DOI: 10.3390/ijms222212429] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu M, Zhang T, Xia R, Wei Y, Wei X. Targeting the tumor stroma for cancer therapy. Mol Cancer 2022;21:208. [PMID: 36324128 DOI: 10.1186/s12943-022-01670-1] [Reference Citation Analysis]
2 Rühle A, Lies M, Strack M, Perez RL, Bieber B, Thomsen AR, Bronsert P, Huber PE, Hess J, Knopf A, Wuchter P, Grosu A, Nicolay NH. Human Mesenchymal Stromal Cells Do Not Cause Radioprotection of Head-and-Neck Squamous Cell Carcinoma. IJMS 2022;23:7689. [DOI: 10.3390/ijms23147689] [Reference Citation Analysis]
3 Lederer CW, Koniali L, Buerki-thurnherr T, Papasavva PL, La Grutta S, Licari A, Staud F, Bonifazi D, Kleanthous M. Catching Them Early: Framework Parameters and Progress for Prenatal and Childhood Application of Advanced Therapies. Pharmaceutics 2022;14:793. [DOI: 10.3390/pharmaceutics14040793] [Reference Citation Analysis]